Brief: Yichang Hec Changjiang Pharmaceutical Posts FY Profit And Total Comprehensive Income Attributable RMB1,992.62 Mln
March 28 (Reuters) - YiChang HEC ChangJiang
Pharmaceutical Co Ltd 1558.HK :
* FY PROFIT AND TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE
RMB1,992.62 MILLION, UP 2,501.23%
* FY REVENUE RMB6,294.59 MILLION, INCREASE OF 68.08
* RESOLVED NOT TO RECOMMEND PAYMENT OF FINAL DIVIDEND FOR
YEAR
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million